This program focuses on dissemination of emerging clinical evidence and comprehensive oral and intravenous pharmacotherapy management strategies. The exponential growth of therapies, along with the increased utilization of multiple lines of therapies call for close oversight of rapidly expanding therapeutic options. In addition, advances in diagnostics expanding precision medicine modalities increasingly guide individualized therapy options. With vast emerging scientific evidence on all fronts, it is essential for pharmacists to be equipped with cutting-edged education on evidenced-based treatment options for their patients. Lastly, this conference focuses on identifying best practices addressing the unique challenges and opportunities in the local market of Puerto Rico, aiming to leverage patient access to therapies while driving efficiencies and value for all stakeholders involved, including the specialty pharmacies and health plans.

This summit will bring focus to clinical and practical considerations for emerging specialty pharmaceuticals in a wide variety of oncology and malignant hematology conditions, as well as breakthrough pharmacotherapy advancements in the areas of neurology, endocrinology, weigh management and weigh management in the context of the diabetic patient, among others. The summit content emphasizes the importance and role of the pharmacists in patient adherence and validated monitoring and adherence tools will be shared as avenues to best manage optimal therapy outcomes. Furthermore, the summit brings experts together to identify potential avenues to drive value through utilization of biosimilars, 505(b)(2) products and other emerging classes. All clinical and practical considerations will be focused on the challenges and opportunities facing the ecosystem of stakeholders (e.g., patient, pharmacy, payer, manufacturer) that collectively impact access to specialty pharmaceuticals.